Literature DB >> 598349

Genetic and environmental factors affecting host response to drugs and other chemical compounds in our environment.

E S Vesell, G T Passananti.   

Abstract

Compared to laboratory animals, humans are extremely heterogenous with respect to the many factors that can influence the distribution and biological effects of toxic chemicals. This heterogeneity can prevent an accurate assessment of the impact of a particular toxic compound on the health of an individual subject. Some of the factors that can significantly modify the host response to certain drugs, which serve in this review as a model for environmental chemicals, are enumerated and discussed. Although the mechanisms by which many of these factors modify the biological effects of certain environmental chemicals and drugs have been determined in some cases, better definition of the nature of interactions between these factors and environmental chemicals in a particular individual is required at a biochemical and molecular level. Recommendations are offered for the further development of our knowledge concerning interactions between environmental chemicals and such factors in a particular individual.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 598349      PMCID: PMC1637319          DOI: 10.1289/ehp.7720159

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  70 in total

1.  Temporal variations in acetaminophen and phenacetin half-life in man.

Authors:  C A Shively; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The physiological disposition of dicumarol in man.

Authors:  M WEINER; S SHAPIRO; J AXELROD; J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1950-08       Impact factor: 4.030

3.  The fate of antipyrine in man.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

Review 4.  Kidney disease and drug metabolism.

Authors:  M M Reidenberg
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

5.  Individualization of drug dosage in patients with renal disease.

Authors:  L Dettli
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

6.  Inhibition of drug metabolism in man.

Authors:  E S Vesell; G T Passananti
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

7.  Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.

Authors:  S E Smith; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

8.  Quinine disposition during malaria and during induced fever.

Authors:  G M Trenholme; R L Williams; K H Rieckmann; H Frischer; P E Carson
Journal:  Clin Pharmacol Ther       Date:  1976-04       Impact factor: 6.875

9.  The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.

Authors:  J J BURNS; R K ROSE; T CHENKIN; A GOLDMAN; A SCHULERT; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1953-11       Impact factor: 4.030

10.  Interaction between antipyrine and aminopyrine.

Authors:  E S Vesell; G T Passananti; G W Hepner
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

View more
  1 in total

Review 1.  Fetal drug metabolism and its possible clinical implications.

Authors:  B Krauer; P Dayer
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.